Evaluating the value of Alzheimer's disease diagnosis: A social return on investment analysis

This research focusses on how people are diagnosed with Alzheimer's disease. The study aims to assess the impact of a definitive diagnosis of Alzheimer’s disease from a societal perspective. This includes a clinical (e.g. ability to live independently), humanistic (e.g. ability to contribute to family life and quality of life) and economic (e.g. ability to work) perspective. 

You may be eligible to participate in this research if you: 

• are living with Alzheimer’s disease
• have potential symptoms of Alzheimer’s disease or another type of dementia. 
• are a family member or caregiver for a person living with Alzheimer's disease.

HTANALYSTS will be conducting telephone or videoconference interviews and brief follow-up surveys with participants. Interviews are 30 min to 1 hour long and conducted via telephone or over Microsoft Teams. The follow-up survey will be conducted via an online platform or via telephone.

Any personal details shared during the interviews or surveys will not be shared publicly.